Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Comment: Fulvestrant improves survival over anastrozole for patients with...
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
Tamoxifen lowered breast cancer rates among high-risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
16 Dec 2014
Fulvestrant versus anastrozole in patients with advanced breast cancer
Prof John Robertson - Royal Derby Hospital, Derby, UK
Fulvestrant versus anastrozole in patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )
16 Dec 2014
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple...
Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
High tumour immune cell levels may help screen HER2-positive breast cancer...
Dr Edith Perez - Mayo Clinic, Rochester, USA
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
12 Dec 2014
CLL at ASH 2014: Expert discussion
Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Progression-free survival results from BOLERO-1 trial
Prof Sara Hurvitz - University of California, Los Angeles, USA
Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Examining cell-free DNA provides non-invasive detection of malignancies in...
Dr Peter Vandenberghe - Universitair Ziekenhuis Leuven, Leuven, Belgium
Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma ( Dr Peter Vandenberghe - Universitair Ziekenhuis Leuven, Leuven, Belgium )
12 Dec 2014
Best of ASH 2014
Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert...
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation